Search
A five-year grant of more than $1.4 million will fund a program to train nurses in helping survivors achieve the best possible quality of life after cancer.
Read about the latest MSK research to make CAR T therapy effective against solid tumors.
New MSK research finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.
A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.
Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer.
For people who are unable to find a matched bone marrow or stem cell donor, a cord blood transplant may offer the best chance for being cured of blood cancer.
An effort to develop a radiation test after 9/11 inspires a trip through medical history.
Learn what bladder cancer symptoms can mean in men and women.
Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.